trial

Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis

NCTId NCT01570972
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 103 (actual)
Sponsored by University of Arizona
Primary completion 2017-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
103 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2010-02
Primary completion
2017-04
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
Group Cognitive Behavioral TherapyMultifamily Group Psychoeducation

Sponsors

University of ArizonaLead Sponsor

Investigators

1
Nicholas Breitborde, Ph.D.Principal Investigator

Sites

1 total
Tucson, United States

Facts & assertions

4 sourced
Enrollment
103
Phase
NA
Primary Completion Date
2017-04
Status
COMPLETED
relationships
The graph out of here
drug
Group Cognitive Behavioral Therapy
drug
Multifamily Group Psychoeducation
drug
lead_sponsor
University of Arizona
company
indication
Psychotic Disorder Not Otherwise Specified (NOS)
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
Nicholas Breitborde, Ph.D.
person